Medical Cannabis
Science-led insight on therapeutic use, formulations, and clinical best practice.
Medical Cannabis · page 2
- Cultivation
Why Pharmaceutical Standards Matter More Than Cannabis Branding
James Duckenfield, CEO of Glass Pharms®, dives into the responsibilities behind a medical cannabis brand and why pharmaceutical standards should matter more than marketing.
- Medical Cannabis
Germany to Soften Cannabis Insurance Reforms as Exilby Lobbying Row Escalates
Germany’s coalition government has retreated further on its controversial medical cannabis reimbursement reforms as it faces mounting questions over how and why the law came to be.
- Medical Cannabis
Medical Cannabis Pioneer Bedrocan Fights to Avoid Bankruptcy in Home Market
Bedrocan, the Dutch medical cannabis stalwart thousands of patients rely on for their prescriptions, is now fighting to avoid collapse.
- Medical Cannabis
Overdue ACMD Report Gets New Deadline as Industry Weighs In
By Ben Stevens, with additional reporting by Nicole Farah, Managing Director of Americana Communications.
- Cultivation
France’s PGP Farmer Selects 5 Cannabis Strains for Future French Production as Market Nears Rollout
PGP Farmer, the French biotech building the country’s first EU-GMP medical cannabis production site, has narrowed a 30-variety Dutch phenotyping trial to five elite cultivars, laying the agronomic groundwork for its 9-hectare Dordogne facility as France closes on the reforms needed for full medical cannabis rollout.
- Medical Cannabis
UK Medical Cannabis Under Review: Where is the ACMD Report?
Pressure is piling on the UK’s Advisory Council on the Misuse of Drugs (ACMD) to publish its highly anticipated review of the country’s medical cannabis framework.
- Cultivation
Inside Northern Leaf’s Remarkable Turnaround: From Brink of Collapse to £8m Cultivator
Northern Leaf, the Jersey-based medical cannabis cultivator, looked all but certain to follow in the footsteps of Curaleaf, Aurora and Tilray to become the British Isles’ very own international cannabis superstar.
- Medical Cannabis
Majority of UK Medical Cannabis Flower Now at 25% THC or Above, New Data Shows
Earlier this month, we published new data from two separate Freedom of Information (FOI) requests providing the most complete and up-to-date picture yet of the UK’s medical cannabis market.
- Interviews
Remexian Surging Ahead One Year On From High Tide Purchase
Whilst expressing empathy with patients impacted by the recent German crackdown on cannabis flower, the head of the country’s leading wholesaler is bullish about its prospects – with orders up 50% since its purchase by Canadian cannabis giant High Tide.
- Interviews
Is It An Open Goal For Germany’s New Cannabis Medicine?
The imminent launch of the first new European cannabis-based pharmaceutical for over five years could not have been better timed, it seems.
- Medical Cannabis
UK Medical Cannabis Prescriptions Hit 1.7 Million in 2025 as ACMD Review Approaches
More than a year has passed since the Advisory Council on the Misuse of Drugs (ACMD) was commissioned to conduct a formal review of the UK’s medical cannabis industry.
- Medical Cannabis
Cannabis Use Among Teens Flat After German Partial Legalisation, But Medical Market Continues Rapid Expansion
Germany’s Cannabis Act (CanG) has not led to an increase in use among young people, according to new peer-reviewed research adding to the growing body of evidence contradicting the harms predicted by the reform’s critics.
